Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene by unknown
Constitutive Expression of Parathyroid Hormone-
Related Protein Gene in Human T Cell Leukemia
Virus Type 1 (HTLV1) Carriers and Adult T Cell
Leukemia Patients that Can Be irans-Activated by
HTLV1 tax Gene
By Toshiki Watanabe,* Kazunari Yamaguchi,$ Kiyoshi Takatsukij
Mitsuhiro Osame,§ and Mitsuaki Yoshida*
From the "Department of Viral Oncology, Cancer Institute, Toshima-ku, Tokyo 170,
the #Second Department of Internal Medicine, Kumamoto University Medical School,
Kumamoto 860, and the SThird Department of Internal Medicine, Kagoshima University
Medical School, Kagoshima 890, Japan
Summary
Adult T cell leukemia (ATL) is associated with human T cell leukemia virus type 1 (HTLV--1)
infection, and almost all ATL patients have the complication of hypercalcemia. To understand
the mechanism of the high incidence of hypercalcemia in ATL, we studied the expression of
a parathyroid hormone-related protein (PTHrP) gene that has been proposed as a causative factor
of hypercalcemia in some solid tumors. The polymerase chain reaction coupled with reverse
transcription of mRNA was applied to RNA from peripheral blood mononuclear cells. Cells
from all 13 ATL patients examined showed abundant expression of the PTHrP gene, while cells
from uninfected normal subjects did not. Significant expression of PTHrP gene was also detected
in HTLV1 carriers without any symptoms and in patients with HTLV1-associated myelopathy
or tropical spastic paraparesis. PTHrP mRNA levels correlated with the number of infected cells
that were estimated by the integrated HTLV1 DNA. These results suggest that HTLV1-infected
cells are expressing the PTHrP gene. This concept was further supported by the finding that
the HTLV--1 trans-activator, the tax gene product, caused trans-activation of the PTHrP gene promoter
linked to the CAT gene. These observations might explain the general expression of the PTHrP
gene in ATL patients and the high incidence of hypercalcemia in ATL.
A
dult T cell leukemia (ATL)t is a unique T cell malig-
nancy associated with human T cell leukemia virus type
1 (HTLV1) (1, 2). HTLV--1 is also associated with a chronic
progressive myelopathy, designated as HTLV1-associated my-
elopathy or tropical spastic paraparesis (HAM/TSP) (3, 4).
One of the clinical characteristics of ATL is hypercalcemia,
and almost all ATL patients show abnormal calcium metab-
olism: marked increase of osteoclastic bone resorption, uri-
nary excretion of calcium, and nephrogenous cyclic AMP.
These abnormalities were detected even in patients who do
not show apparent hypercalcemia (5, 6). IIJ1 has been impli-
cated as a possible causative factor of the hypercalcemia in
'Abbreviations used in this paper . ATL, adult T cell leukemia; GM,
granulocyte/macrophage; HAM, HTLV1-associated myelopathy;
HTLV--1, human T cell leukemia virus type 1; PTHrP, parathyroid
hormone-related protein; RT, reverse transcription; TSP, tropical
spastic paraparesis.
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ATL, because of its osteoblast-activating effect and its produc-
tion by some ATL cells (7, 8). However, the presence of sys-
temic metabolic derangements similar to those seen in pri-
mary hyperparathyroidism (9) are not satisfactorily explained
by the actions of 11,1.
A parathyroid hormone-related protein (PTHrP) has re-
cently been proposed as a humoral factor of hypercalcemia
in some solid tumors (10-12). Overproduction ofparathyroid
hormone (PTH) induces the systemic abnormality of calcium
metabolism known as primary hyperparathyroidism, and the
NH2-terminal region of PTH shows homology to that of
the PTHrP (13-15) . The NH2-terminal 34 amino acids of
both proteins show similar effects on renal and osteoblast cell
membranes in vitro, and on calcium and inorganic phosphate
fluxes in vivo (16-18). These observations seem to explain
the similarities in the syndromes ofhumorally mediated hyper-
calcemia of malignancy and primary hyperparathyroidism (9).
We have demonstrated previously that an HTLV1-infected
T cell line, MT-2 cells, produced a factor that stimulated ade-
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mRNA expressed in MT-2 cells was homologous to the
PTHrP mRNA gene (19, 20). Expressionofa PTHrP-related
gene was detected in a few cases of ATL using oligonucleo-
tide probes, thus, the PTHrP has been suggested to be as-
sociated with hypercalcemia in ATL (21, 22). However, the
oligonucleotide hybridization assay gave positive results in
only a few cases of ATL because of its sensitivity.
To examine PTHrP gene expression in ATL more widely,
we applied the PCR coupled with reverse transcription of
mRNA to the investigation ofPBMC. 13 patients with ATL,
four patients with HAM/TSP, and four healthy HTLV1 car-
rierswere all found to express PTHrP gene in vivo. This sug-
gests that HTLV1 infection induced the expression of the
PTHrP gene. We also found that the HTLV1 tax gene trans-
activated the PTHrP gene promoter in cotransfection assays.
Materials and Methods
Cells.
￿
MT-2 is a human T cell line infected with HTLV-1(23),
and CEM and Jurkat are noninfected human T cell lines. PBMC
were prepared by Ficoll-Hypaque (Pharmacia Fine Chemicals, Upp-
sala, Sweden) density gradient centrifugation.
RNA Preparation.
￿
RNA from the cell lines or from PBMCs
was isolated by the ribonucleoside-vanadyl complex method (24),
and then polyadenylated RNA was separated using oligo-dT--cel-
lulose.
Reverse Transcription-coupled PCR (RTPCR).
￿
For detection of
PTHrP mRNA, the RTPCR was applied as follows (25-27).
Samples of 1 .ug oftotal cytoplasmic RNA underwent reverse tran-
scription by Moloney murine leukemia virus RT (Bethesda Re-
search Laboratories, Gaithersburg, MD) using oligo(dT) as primers.
1/20 of the cDNA was subjected to PCR. The primers used were
21 mers derived from the exon 2 and exon 3 sequences of PTHrP
(28), so that the PCR product derived from the cDNA could easily
be distinguished from that derived from genomic DNA. DNA in
the PCR mixture was denatured at 95°C for 1 min, and annealed
at 55°C for 2 min. Polymerization was carried out at 70°C for
1 .5 min. These reactions were repeated for 50 cycles.
The PCR . products were analyzed either by Southern blotting
orby liquid hybridization followed by gel electrophoresis. For liquid
hybridization (28), the PCR products were denatured at 98°C for
15 min and hybridized with a "Polgonucleotide probe at 55°C
for 45 min in 1x SSC. The mixture was then separated by PAGE,
and the gel was exposed to x-ray film for autoradiography. The
radioactivity of a specific band was measured for quantitation of
the amplified DNA.
Construction and Transfection ofPlasmidsand CATAssay.
￿
To con-
struct the pPTHrP-CAT plasmid that contained the putative pro-
moter ofthe PTHrP gene, a 2.8-kbp HindIII-BaII fragment covering
the 5' flanking region of the PTHrPcoding sequence (29, 30) was
inserted immediately upstream to the CAT gene, thus replacing
the SV40 sequenceofpSV2CAT (31). The pLTR-CAT plasmid (32)
contained the HTLV1 LTR as the promoter. The pRSV55Tax
plasmid was a tax expression plasmid containing an RSV enhancer
linked to the HTLVI promoter (33). The pRSV55-neo plasmid
had a neomycin-resistant gene instead ofthe tax gene, and was used
as a negative control. 5 gg of each CAT plasmid was cotransfected
with 1 Etg ofpRSV55tax or pRSV55-neo into Jurkat cells by the
DEAE-dextran procedure (34). After 40 h of incubation, cell ly-
sates were prepared and CAT activity was measured as described
previously (32, 33). The activation of CAT gene expression was
indicated by the ratio ofCAT activity with the pRSV55tax plasmid
to that with the pRSV55-neo plasmid. Results were averages of
more than three experiments.
Results
PTHrP mRNA in MT-2 Cells.
￿
We have previously reported
that MT-2 cells, a T cell line infected with HTLV1(23), pro-
duced a factor that stimulated adenylate cyclase activity in
osteoblast membranes, and also expressed multiple species of
mRNA (19) that hybridized with the oligonucleotide probe
of PTHrP cDNA (13). To characterize these multiple forms
of mRNA, we isolated several cDNA clones using an oligo-
nucleotide probe. Structural analysis of these cDNA clones
revealed multiple forms of mRNA that had an identical open
reading framecoding for PTHrP (13-15, 35), but these differed
in the 3' noncoding sequences by alternative splicing and also
by alternative polyadenylation (data not shown; see Fig. 1).
Thus, the mRNAs detected in MT-2 cells were those of
PTHrP, and the PTHrP was suggested to be the adenylate
cyclase-stimulating factor present in the culture medium (20).
Expression ofthe PTHrP Gene inATL Cells.
￿
We first studied
the expression ofthe PTHrP gene in leukemic T cells of ATL
patients by Northern blot hybridization using the cDNA as
a probe. A few samples of ATL gave a positive result, showing
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Figure 1.
￿
Genomic organization of the PTHrP gene (27, 39) and
region of amplification in PTHrP mRNA using the RTPCR (A).
The organization of the gene (~ and of the mRNAs (11) are shown
schematically. Open boxes represent coding exons, and hatched boxes
represent noncoding exons that are alternatively spliced. mRNA in i
represents multiple forms terminated at different polyadenylation sites
(An). The sequences used as primers (P2 and P3) and as the hybrid-
ization probe (P2 PR1) are shown in B. The nucleotide positions are
those in the cDNA sequence reported by Thiede et al. (15).multiple bands (Fig. 2), the pattern of which was basically
the same as that of MT-2 cellular RNA. These results
confirmed that the PTHrP gene was expressed in fresh cells
from ATL patients, and the extent ofmRNA expression was
comparable with that in MT-2 cells, as judged from the in-
tensities of the bands and the amount ofRNA applied to
the gel .
This type of analysis requires a largenumber of fresh leu-
kemic cells to get intact mRNA . In practice, at least 0.5 wg
ofpoly(A)-containingRNA was required, which was equiva-
lent to 10-30 i4g of total cytoplasmic RNA or 107 normal
PBMC . To establish a more sensitive assay, we applied the
PCR coupled with reverse transcription ofmRNA (RTPCR)
(25-27). Total cytoplasmic RNA extracted from the fresh
or frozenPBMC of theATL patients underwent reverse tran-
scription into cDNA using oligo(dT) as a primer, and then
the PTHrP gene sequence was amplified by the PCR, as de-
scribed in Materials and Methods. The sequences corre-
sponding to exons 2 and 3 were used as primers so that all
species ofmRNA could be detected and so that the DNA
amplified from cDNA could be distinguished from DNA
arising from contaminating cellular DNA . After 50 cycles
ofPCR, the product was analyzed by agarose gel electropho-
resis followed by staining with ethidium bromide or Southern
hybridization .
On staining the gels, a specific band with the expected
size (Fig. 3A, arrow) was visible as a major signal in all samples
from the 13 ATL patients tested, while no such band was
visible in preparations from uninfected healthy donors (Fig.
3 A) . The other bands were also detected in some samples.
However, these were not reproducible and did not hybridize
with the PTHrP probe, thus, they were concluded to be
nonspecific products . The identity of this amplified DNA
was confirmed by Southern blot hybridization with an oli-
gonucleotide probe corresponding to the sequence between
the two primers used for the PCR. The specifically stained
band hybridized very strongly with this oligonucleotide probe
(Fig. 3 B) . On the other hand, samples from normal donors
showed no hybridization signal, although they gave a very
faint signal after a 10-fold longer exposure . Similar results
were obtained using another pair of primers of exons 1 and
2 (data not shown) . In control experiments, (3 actin primers
produced almost constant amounts of amplified DNA in all
Figure 2 . Detection of
PTHrP mRNA in PBMC of
ATL patients by Northern blot
hybridization . Poly(A)-con-
taining RNA from MT-2 cells
(lane 1), normal donor PBMC
(lane 2), and ATL PBMC
(lanes 3-5) were applied, but
in different amounts because of
the limitations of the samples :
0 .5 Ag (lanes 1-3), 0.3 ug
(lane 4), and <0.1 jAg (lane 5) .
The filter was hybridized with
the full cDNA of PTHrP.
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samples, indicating the specific expression of thePTHrP gene
in the ATL samples (Fig. 3 C) .
To estimate the levels ofPTHrP mRNA, quantitation of
the amplifiedDNA was performed as follows. After the RT
PCR, part of the amplified DNA was hybridized with an
oligonucleotide probe at 55°C for 45 min . The hybridized
materials were then separated in a polyacrylamide gel, and
the radioactivities of specific bands were measured . The ra-
dioactivity of the specific bands showed a linear relationship
Figure 3 .
￿
Detection of PTHrP mRNA in ATL samples by the
PCR coupled with reverse transcription. Reverse transcription of cel-
lular RNA (1.0 ug total RNA) and the PCR were carried out as de-
scribed in Materials and Methods . One-fifth of the PCR mixture was
analyzed by ethidium bromide staining of the gel (A) and by hybrid-
ization with the oligonucleotide probe of PTHrP cDNA . The film
was exposed for 3 h (B). (C) Agarose gel electrophoresis ofDNA
amplified by 0-actin primers. Lane 1, CEM cells ; lane 2, normal
donor cells ; lane 3, normal donor cells stimulated for 40 h by PHA ;
lanes 4-11, cells from ATL patients; lane 12, MT-2 cells . Molecular
marker, Bgll/Hinfl digest of pBR328 . Arrowhead indicates the posi-
tion of the specifically amplified DNA .3-
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Quantitative anal- . 1
ysis of the pTHrP mRNA
level. MT-2 RNA was serially
diluted fourfold with CEM
RNA and subjected to the
RTPCR . The amplified DNA
was hybridized with a 12p-la-
beled oligonucleotide probe,
and the hybrids were separated
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bands were counted and plotted.
to the amount ofmRNA using a fourfold serial dilution of
MT-2 RNA (Fig. 4) . Using this system, we found that 9
of 13 ATL patients expressedpTHrPmRNA at several times
the level of theMT-2 cell line. The other four patients showed
weaker expression, varying from an equivalent expression to
that of MT-2 cells down to roughly 1/10 of this level . The
abundant level ofpTHrPmRNA expression suggested that
the leukemic cells expressed the pTHrP gene in vivo .
pTHrP Gene Expression in Infected Cells.
￿
The expression
of the pTHrP gene in leukemic T cells raised the question
of whether HTLV1-infected cells expressed the pTHrP gene
before malignant transformation, since leukemic cells are always
infected with HTLV1 . To examine this, we surveyed PBMC
ofHTLV1 carriers who were either without any symptoms
or with HAM/TSP (3, 4) . HAM/TSP patients were included
in this survey because they showed more expansion ofHTLV-
1-infected T cells than did asymptomatic carriers (36) . As
shown in Fig. 5, all eight samples ofHTLV1 carriers tested
expressed significantly higher levels ofpTHrPmRNA than
did uninfected normal controls (lanes 3-10) . In some cases,
the levels were significantly higher than in the PHA-stimulated
PBMC of uninfected donors (Fig . 5, lane 2), where all the
T cells were activated. These findings suggested that HTLV1
infection induced expression of thepTHrP gene before malig-
nant transformation .
To determine the correlation between the pTHrP gene ex-
pression and the population ofHTLV1-infected T cells, the
samples tested for pTHrP expression were subjected to
Southern blot analysis to determine HTLV1 DNA . Based
on the intensities of the blots (see Fig. 6 B), the fraction of
HTLV1-infected cells were classified into five grades : non-
detectable, and detectable in +1, +2, +3, and +4 (Fig . 6
A) . The sample distribution of the grades of infected cells
roughly correlated with the pTHrP gene expression . These
findings strongly suggested that HTLV1-infected cells in
asymptomatic carriers or HAM/TSP patients expressed the
pTHrP gene. However, when the level ofpTHrP expression
was compared between ATL and non-ATL samples, the ex-
pression in ATL samples was found to be higher than ex-
pected from the population of infected cells. Thus, some
Figure 5 .
￿
Detection of pTHrP mRNA in PBMC of HTLV1 car-
riers and HAM/TSP patients. All samples were processed as described
in Fig . 3 for hybridization with the pTHrP probe, except for the expo-
sure time of 36 h . Lanes 1 and 2, PBMC from normal donors, fresh
and PHA stimulated, respectively ; lanes 3-6, PBMC from asymptom-
atic carriers ; lanes 7-10, PBMC from HAM/TSP patients . The ar-
rowhead indicates the position of the specifically amplified DNA .
factor(s) other than HTLV--1 infection, such as transforma-
tion of infected cells, might be further activatingpTHrP gene
expression .
trans-activation ofthepTHrP Promoter byHTLV1 tax.
￿
Ex-
pression of the pTHrP gene in HM-1-infected cells strongly
suggested that this gene expression might be directly trans-
activated by the tax gene product of HTLV1, since tax can
activate the transcription of cellular genes like IIT2, IIr2R,
or granulocyte/macrophage (GM)-CSF, as well as the HTLV1
genome (32, 36-39) . To examine this possibility, we con-
structed thepPTHrP-CAT plasmid by inserting the 2.8-kbp
fragment containing the promoter region ofthe pTHrP gene
(29, 30) into upstream of the CAT gene (Fig. 7 A) . After
transfecting this plasmid with or without a tax expression
plasmid, pRSV55Tax, the CAT activities expressed in cells
were measured. CAT expression was enhanced 15-fold by the
tax plasmid, although this was less than with thepLTRCAT
plasmid (Fig. 7 B) . Therefore, the promoter ofpTHrP was
demonstrated to be trans-activated by the viral trans-activator
tax . This could be one mechanism by which HTLV1-infected
cells express the pTHrP gene.
Discussion
In this study, we demonstrated that all 13 ATL patients
tested expressed the pTHrP gene in comparable levels with
the MT-2 cell line. Expression of thepTHrP gene in allATL
patients would explain the high incidence of hypercalcemia
in AM This hypothesis is based on reports that pTHrP is
one of the main factors responsible for hypercalcemia ofcancer
(10-14, 40, 41) . TheATL patients studied here included both
hypercalcemic and normocalcemic individuals, and a high level
ofpTHrP gene expression was not necessarily correlated with
clinically evident hypercalcemia. However, these observations
on pTHrP expression and hypercalcemia are not conflicting,
because as we have reported previously (6, 22), most ATL
patients show clinical evidences of calcium mobilization, such
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￿
Levels of expression of the PTHrP gene in HTLV1 carriers, HAM/TSP patients, and ATL patients. (A) Levels of PTHrP mRNA
were estimated using the standard curve shown in Fig. 4, and are shown relative to levels in MT-2 cells. (O) Values for individual PBMC
samples; (/) MT-2 cells ; (EI) PHA-stimulated PBMC from an uninfected normal donor. On the left side, the HTLV1-infected cells in the
samples are classified into five grades by the intensity of the HTLV1 DNA bands in Fig. 5 B . (B) Estimation ofHTLV1 proviral DNA levels in
PBMC samples. Cellular DNA was isolated from PBMC at the time of RNA preparation, and Pstl-digested samples of 10 Wg were examined
for integrated HTLVI proviral DNA by Southern hybridization using the whole sequence ofHTLV1 DNA as a probe. Lane 1, CEM cells ;
lanes 2-5, cells from asymptomatic carriers ; lanes 6-9, cells from HAM/TSP patients ; lanes 10-18, cells from ATL patients; lane 19, MT-2 cells.
Figure 7 .
￿
Activation of the PTHrP promoter by the tax gene of
HTLV1 . pPTHrP-CAT was constructed from pSV2-CAT by replacing
the SV40 promotor sequence with the PTHrP gene promotor frag-
ment (A) H, HindIII ; X, Xbal; B, BamHI . Arrow indicates putative
transcription starting site. pPTHrP was cotransfected with
pPSV55Tax, a tax expression plasmid, or with a control plasmid,
pRSVneo . Activation shows the ratio ofCAT activity in cells cotrans-
fected with pRSV55Tax with respect to cells cotransfected with
pRSV55neo, and is an average of more than three experiments (B) .
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as hypercalciuria and the increased urinary excretion of
nephrogenous cyclic AMP. Elevation of the blood calcium
level would be the consequence of the breakdown ofthe mech-
anism maintaining homeostasis, mainly due to a long-term
massive load of mobilized calcium and the subsequent de-
terioration of renal function .
The level ofPTHrP expression correlated with the popu-
lation ofATL cells in the patients . This observation strongly
suggested that malignant ATL cells produced PTHrP, which
would explain the high incidence of hypercalcemia in ATL .
We also demonstrated expression ofthe PTHrP gene in asymp-
tomatic HTLV1 carriers and patients with HAM/TSP, and
the expression level was correlated with the population of
infected cells. Therefore, it was concluded that HTLV1 in-
fection induced the PTHrP gene expression . As a possible
mechanism of this induction, direct trans-activation by the
tax gene of HTLV1 was tested . The putative promoter in
pPTHrP-CAT was significantly trans-activated by cotransfec-
tion with tax, in a similar manner to IL2Rci and GM-CSF
gene expression (37, 39) . However, it is known that in the
peripheral blood cells of ATL patients, viral genes are not
expressed or are expressed at a very low level. Thus, some
other cellular function(s) may also be involved in the consti-
tutive expression of the PTHrP gene.
Although there were considerable variations in individual
responses, the PTHrP expression in ATL was much higher
than that expected in proportion to the number of infected
cells . The number ofHTLV1-infected cells in ATL patients
was 20-50 times that in HAM/TSP patients (see Fig. 5),
but in some ATL cases, 1,000-fold higher expression of the
PTHrP gene than those in HAM/TSP patients was observed .
Therefore, some factor(s) other than the HTLV1 tax gene,
for example, a factor associated with malignant transforma-
tion, may further enhance the expression ofthe PTHrP gene.In summary, our observations strongly suggested that
PTHrP gene expression was induced by HTLV1 infection
through trans-activation by the tax gene andwas further ac-
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